LRMR – larimar therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Larimar Therapeutics (NASDAQ:LRMR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Larimar Therapeutics Reports Third Quarter 2025 Financial Results
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Form 8-K Larimar Therapeutics, For: Jan 12
Form 8-K Larimar Therapeutics, For: Dec 16
Form 8-K Larimar Therapeutics, For: Nov 10
Form SCHEDULE 13G/A Larimar Therapeutics, Filed by: MILLENNIUM MANAGEMENT LLC
Form 10-Q Larimar Therapeutics, For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.